{
  "DOI": "10.1186/1479-7364-5-3-200",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/1479-7364-5-3-200",
  "alternative-id": [
    "297"
  ],
  "article-number": "200",
  "author": [
    {
      "affiliation": [],
      "family": "Valerio",
      "given": "Luis G",
      "sequence": "first",
      "suffix": "Jr"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2012,
        7,
        16
      ]
    ],
    "date-time": "2012-07-16T12:15:11Z",
    "timestamp": 1342440911000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        2,
        17
      ]
    ],
    "date-time": "2020-02-17T21:56:19Z",
    "timestamp": 1581976579000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        26
      ]
    ],
    "date-time": "2024-03-26T21:51:52Z",
    "timestamp": 1711489912308
  },
  "is-referenced-by-count": 34,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2011,
        3,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2011,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            3,
            1
          ]
        ],
        "date-time": "2011-03-01T00:00:00Z",
        "timestamp": 1298937600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/1479-7364-5-3-200.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/1479-7364-5-3-200/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/1479-7364-5-3-200.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2011,
        3,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        3,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "EU",
      "first-page": "1",
      "journal-title": "OJEU",
      "key": "297_CR1",
      "unstructured": "EU: Regulation (EC) No 1907/2006 of The European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94, as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. OJEU. 2006, L396: 1-843. (EC 1907/2006)",
      "volume": "L396",
      "year": "2006"
    },
    {
      "author": "NRC",
      "key": "297_CR2",
      "unstructured": "NRC: Toxicity Testing in the 21st Century: A Vision and a Strategy. 2007, National Academy Press, Washington, DC",
      "volume-title": "Toxicity Testing in the 21st Century: A Vision and a Strategy",
      "year": "2007"
    },
    {
      "author": "FDA",
      "key": "297_CR3",
      "unstructured": "FDA: Critical Path Initiative. 2010, US Department of Health and Human Services, Rockville, MD, (accessed 15th June, 2010), [\n                    http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/default.htm\n                    \n                  ]",
      "volume-title": "Critical Path Initiative",
      "year": "2010"
    },
    {
      "author": "FDA",
      "key": "297_CR4",
      "unstructured": "FDA: Challenge and opportunity on the critical path to new medical products. 2004, US Department of Health and Human Services, US Food and Drug Administration, Rockville, MD, [\n                    http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm()77262.htm\n                    \n                  ]",
      "volume-title": "Challenge and opportunity on the critical path to new medical products",
      "year": "2004"
    },
    {
      "DOI": "10.1177/026119290903700509",
      "author": "C Yang",
      "doi-asserted-by": "crossref",
      "first-page": "523",
      "journal-title": "Altern Lab Anim",
      "key": "297_CR5",
      "unstructured": "Yang C, Valerio LG, Arvidson KB: Computational toxicology approaches at the US Food and Drug Administration. Altern Lab Anim. 2009, 37: 523-531.",
      "volume": "37",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.taap.2009.08.022",
      "author": "LG Valerio Jr",
      "doi-asserted-by": "publisher",
      "first-page": "356",
      "journal-title": "Toxicol Appl Pharmacol",
      "key": "297_CR6",
      "unstructured": "Valerio LG: In silico toxicology for the pharmaceutical sciences. Toxicol Appl Pharmacol. 2009, 241: 356-370. 10.1016/j.taap.2009.08.022.",
      "volume": "241",
      "year": "2009"
    },
    {
      "DOI": "10.1002/mnfr.200900259",
      "author": "LG Valerio Jr",
      "doi-asserted-by": "publisher",
      "first-page": "186",
      "journal-title": "Mol Nutr Food Res",
      "key": "297_CR7",
      "unstructured": "Valerio LG, Arvidson KB, Busta E, Minnier BL, et al: Testing computational toxicology models with phytochemicals. Mol Nutr Food Res. 2010, 54: 186-194. 10.1002/mnfr.200900259.",
      "volume": "54",
      "year": "2010"
    },
    {
      "DOI": "10.1177/0960327108097689",
      "author": "LG Valerio Jr",
      "doi-asserted-by": "publisher",
      "first-page": "757",
      "journal-title": "Hum Exp Toxicol",
      "key": "297_CR8",
      "unstructured": "Valerio LG: Tools for evidence-based toxicology: Computational-based strategies as a viable modality for decision support in chemical safety evaluation and risk assessment. Hum Exp Toxicol. 2008, 27: 757-760. 10.1177/0960327108097689.",
      "volume": "27",
      "year": "2008"
    },
    {
      "DOI": "10.1517/17425250903499286",
      "author": "LG Valerio Jr",
      "doi-asserted-by": "publisher",
      "first-page": "505",
      "journal-title": "Expert Opin Drug Metab Toxicol",
      "key": "297_CR9",
      "unstructured": "Valerio LG, Yang C, Arvidson KB, Kruhlak NL: A structural feature-based computational approach for toxicology predictions. Expert Opin Drug Metab Toxicol. 2010, 6: 505-518. 10.1517/17425250903499286.",
      "volume": "6",
      "year": "2010"
    },
    {
      "DOI": "10.1002/mnfr.200900259",
      "author": "LG Valerio Jr",
      "doi-asserted-by": "publisher",
      "first-page": "186",
      "journal-title": "Mol Nutr Food Res",
      "key": "297_CR10",
      "unstructured": "Valerio LG, Arvidson KB, Busta E, Minnier BL, et al: Testing computational toxicology models with phytochemicals. Mol Nutr Food Res. 2010, 54: 186-194. 10.1002/mnfr.200900259.",
      "volume": "54",
      "year": "2010"
    },
    {
      "DOI": "10.1517/17425255.2010.486789",
      "author": "LG Valerio Jr",
      "doi-asserted-by": "publisher",
      "first-page": "781",
      "journal-title": "Expert Opin Drug Metab Toxicol",
      "key": "297_CR11",
      "unstructured": "Valerio LG: Computational science in drug metabolism and toxicology. Expert Opin Drug Metab Toxicol. 2010, 6: 781-784. 10.1517/17425255.2010.486789. [Editorial]",
      "volume": "6",
      "year": "2010"
    },
    {
      "DOI": "10.1021/jm0311487",
      "author": "A Evers",
      "doi-asserted-by": "publisher",
      "first-page": "5381",
      "journal-title": "J Med Chem",
      "key": "297_CR12",
      "unstructured": "Evers A, Klebe G: Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model. J Med Chem. 2004, 47: 5381-5392. 10.1021/jm0311487.",
      "volume": "47",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s00204-010-0528-6",
      "author": "RD Combes",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "journal-title": "Arch Toxicol",
      "key": "297_CR13",
      "unstructured": "Combes RD: Is computational toxicology withering on the vine?. Arch Toxicol. 2010, 84: 333-336. 10.1007/s00204-010-0528-6.",
      "volume": "84",
      "year": "2010"
    },
    {
      "DOI": "10.1021/ci700332k",
      "author": "SR Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "25",
      "journal-title": "J Chem Inf Model",
      "key": "297_CR14",
      "unstructured": "Johnson SR: The trouble with QSAR (or how I learned to stop worrying and embrace fallacy). J Chem Inf Model. 2007, 48: 25-26.",
      "volume": "48",
      "year": "2007"
    },
    {
      "author": "N Greene",
      "first-page": "90",
      "journal-title": "Curr Opin Drug Discov Devel",
      "key": "297_CR15",
      "unstructured": "Greene N, Naven R: Early toxicity screening strategies. Curr Opin Drug Discov Devel. 2009, 12: 90-97.",
      "volume": "12",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.drudis.2009.09.010",
      "author": "C Merlot",
      "doi-asserted-by": "publisher",
      "first-page": "16",
      "journal-title": "Drug Discov Today",
      "key": "297_CR16",
      "unstructured": "Merlot C: Computational toxicology -- A tool for early safety evaluation. Drug Discov Today. 2010, 15: 16-22. 10.1016/j.drudis.2009.09.010.",
      "volume": "15",
      "year": "2010"
    },
    {
      "DOI": "10.1177/026119290903700505",
      "author": "S Boyer",
      "doi-asserted-by": "crossref",
      "first-page": "467",
      "journal-title": "Altern Lab Anim",
      "key": "297_CR17",
      "unstructured": "Boyer S: The use of computer models in pharmaceutical safety evaluation. Altern Lab Anim. 2010, 37: 467-475.",
      "volume": "37",
      "year": "2010"
    },
    {
      "author": "FDA",
      "key": "297_CR18",
      "unstructured": "FDA: Draft guidance for industry: Genotoxic and carcinogenic impurities in drug substances and products: Recommended approaches. 2008, US FDA/CDER, US Department of Health and Human Services, Silver Spring, MD",
      "volume-title": "Draft guidance for industry: Genotoxic and carcinogenic impurities in drug substances and products: Recommended approaches",
      "year": "2008"
    },
    {
      "DOI": "10.1517/17425255.2010.495118",
      "author": "RT Naven",
      "doi-asserted-by": "publisher",
      "first-page": "797",
      "journal-title": "Expert Opin Drug Metab Toxicol",
      "key": "297_CR19",
      "unstructured": "Naven RT, Louise-May S, Greene N: The computational prediction of genotoxicity. Expert Opin Drug Metab Toxicol. 2010, 6: 797-807. 10.1517/17425255.2010.495118.",
      "volume": "6",
      "year": "2010"
    },
    {
      "DOI": "10.1517/17425255.2010.486400",
      "author": "R Benigni",
      "doi-asserted-by": "publisher",
      "first-page": "809",
      "journal-title": "Expert Opin Drug Metab Toxicol",
      "key": "297_CR20",
      "unstructured": "Benigni R, Bossa C, Tcheremenskaia O, Giuliani A: Alternatives to the carcinogenicity bioassay In silico methods, and the in vitro and in vivo mutagenicity assays. Expert Opin Drug Metab Toxicol. 2010, 6: 809-819. 10.1517/17425255.2010.486400.",
      "volume": "6",
      "year": "2010"
    },
    {
      "DOI": "10.1080/15376510701857056",
      "author": "R Benigni",
      "doi-asserted-by": "publisher",
      "first-page": "137",
      "journal-title": "Toxicol Mech Methods",
      "key": "297_CR21",
      "unstructured": "Benigni R, Bossa C: Predictivity and reliability of QSAR models: The case of mutagens and carcinogens. Toxicol Mech Methods. 2008, 18: 137-147. 10.1080/15376510701857056.",
      "volume": "18",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.taap.2009.12.002",
      "author": "N Lee",
      "doi-asserted-by": "publisher",
      "first-page": "146",
      "journal-title": "Toxicol Appl Pharmacol",
      "key": "297_CR22",
      "unstructured": "Lee N, Authier S, Pugsley MK, Curtis MJ: The continuing evolution of torsades de pointes liability testing methods: Is there an end in sight?. Toxicol Appl Pharmacol. 2010, 243: 146-153. 10.1016/j.taap.2009.12.002.",
      "volume": "243",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJMra032426",
      "author": "DM Roden",
      "doi-asserted-by": "publisher",
      "first-page": "1013",
      "journal-title": "N Engl J Med",
      "key": "297_CR23",
      "unstructured": "Roden DM: Drug-induced prolongation of the QT interval. N Engl J Med. 2004, 350: 1013-1022. 10.1056/NEJMra032426.",
      "volume": "350",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.ahj.2009.06.007",
      "author": "JP Piccini",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "journal-title": "Am Heart J",
      "key": "297_CR24",
      "unstructured": "Piccini JP, Whellan DJ, Berridge BR, Finkle JK, et al: Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative. Am Heart J. 2009, 158: 317-326. 10.1016/j.ahj.2009.06.007.",
      "volume": "158",
      "year": "2009"
    },
    {
      "author": "FDA",
      "first-page": "61134",
      "key": "297_CR25",
      "unstructured": "FDA: International Conference on Harmonisation: Guidance on E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs; availability. 2005, 70: 61134-61135. Notice. Department of Health and Human Services",
      "volume-title": "International Conference on Harmonisation: Guidance on E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs; availability",
      "year": "2005"
    },
    {
      "DOI": "10.1517/14740338.4.3.509",
      "author": "I Cavero",
      "doi-asserted-by": "publisher",
      "first-page": "509",
      "journal-title": "Expert Opin Drug Saf",
      "key": "297_CR26",
      "unstructured": "Cavero I, Crumb W: ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: A critical analysis. Expert Opin Drug Saf. 2005, 4: 509-530. 10.1517/14740338.4.3.509.",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.1177/0192623309348521",
      "author": "ME Cartwright",
      "doi-asserted-by": "publisher",
      "first-page": "902",
      "journal-title": "Toxicol Pathol",
      "key": "297_CR27",
      "unstructured": "Cartwright ME, Petruska J, Arezzo J, Frank D, et al: Phospholipidosis in neurons caused by posaconazole, without evidence for functional neurologic effects. Toxicol Pathol. 2009, 37: 902-910. 10.1177/0192623309348521.",
      "volume": "37",
      "year": "2009"
    },
    {
      "DOI": "10.1080/15376510701857262",
      "author": "NL Kruhlak",
      "doi-asserted-by": "publisher",
      "first-page": "217",
      "journal-title": "Toxicol Mech Methods",
      "key": "297_CR28",
      "unstructured": "Kruhlak NL, Choi SS, Contrera JF, Weaver JL, et al: Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicol Mech Methods. 2008, 18: 217-227. 10.1080/15376510701857262.",
      "volume": "18",
      "year": "2008"
    },
    {
      "author": "FDA",
      "key": "297_CR29",
      "unstructured": "FDA: The regulatory challenges of drug-induced phospholipidosis. 2010, Department of Health and Human Services, Bethesda, MD, (accessed 14th June, 2010), [\n                    http://www.fda.gov/downloads/AdvisoryCommittees/Committees.MeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM210798.pdf\n                    \n                  ]",
      "volume-title": "The regulatory challenges of drug-induced phospholipidosis",
      "year": "2010"
    },
    {
      "author": "NAMS. The North American Menopause Society web page",
      "key": "297_CR30",
      "unstructured": "NAMS. The North American Menopause Society web page: Hormone therapy statistics. 2010, NAMS, Mayfield Heights, OH, (accessed 15th May, 2010), [\n                    http://www.menopause.org/hormone-therapystats.aspx\n                    \n                  ]",
      "volume-title": "Hormone therapy statistics",
      "year": "2010"
    },
    {
      "DOI": "10.1146/annurev.nutr.17.1.353",
      "author": "MS Kurzer",
      "doi-asserted-by": "publisher",
      "first-page": "353",
      "journal-title": "Ann Rev Nutr",
      "key": "297_CR31",
      "unstructured": "Kurzer MS, Xu X: Dietary phytoestrogens. Ann Rev Nutr. 1997, 17: 353-381. 10.1146/annurev.nutr.17.1.353.",
      "volume": "17",
      "year": "1997"
    },
    {
      "DOI": "10.1021/jf0014157",
      "author": "J Liu",
      "doi-asserted-by": "publisher",
      "first-page": "2472",
      "journal-title": "J Agric Food Chem",
      "key": "297_CR32",
      "unstructured": "Liu J, Burdette JE, Xu H, Gu C, et al: Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem. 2001, 49: 2472-2479. 10.1021/jf0014157.",
      "volume": "49",
      "year": "2001"
    },
    {
      "DOI": "10.1089/jwh.1998.7.525",
      "author": "S Lieberman",
      "doi-asserted-by": "publisher",
      "first-page": "525",
      "journal-title": "J Women's Health",
      "key": "297_CR33",
      "unstructured": "Lieberman S: A review of the effectiveness of Cimicifuga race-mosa (black cohosh) for the symptoms of menopause. J Women's Health. 1998, 7: 525-529. 10.1089/jwh.1998.7.525.",
      "volume": "7",
      "year": "1998"
    },
    {
      "DOI": "10.1097/gme.0b013e31816054bf",
      "author": "GB Mahady",
      "doi-asserted-by": "publisher",
      "first-page": "628",
      "journal-title": "Menopause",
      "key": "297_CR34",
      "unstructured": "Mahady GB, Dog TL, Barrett ML, Chavez ML, et al: United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause. 2008, 15: 628-638. 10.1097/gme.0b013e31816054bf.",
      "volume": "15",
      "year": "2008"
    },
    {
      "DOI": "10.1097/NT.0b013e3181af63f9",
      "author": "J Betz",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Nutr Today",
      "key": "297_CR35",
      "unstructured": "Betz J, Anderson L, Avigan MI, Barnes J, et al: Black cohosh. Considerations of safety and benefit. Nutr Today. 2009, 44: 155-162. 10.1097/NT.0b013e3181af63f9.",
      "volume": "44",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.yrtph.2010.09.012",
      "author": "WJ Wang",
      "doi-asserted-by": "publisher",
      "first-page": "111",
      "journal-title": "Reg Toxicol Pharmacol",
      "key": "297_CR36",
      "unstructured": "Wang WJ, Dou J, Cross KP, Valerio LG: Computational analysis for hepatic safety signals of constituents present in botanical extracts widely used by women in the United States for treatment of menopausal symptoms. Reg Toxicol Pharmacol. 2011, 59: 111-124. 10.1016/j.yrtph.2010.09.012.",
      "volume": "59",
      "year": "2011"
    },
    {
      "DOI": "10.2174/157016310793180567",
      "author": "LG Valerio Jr",
      "doi-asserted-by": "crossref",
      "first-page": "170",
      "journal-title": "Curr Drug Discov Technol",
      "key": "297_CR37",
      "unstructured": "Valerio LG: The in silico prediction of human-specific metabolites from hepatotoxic drugs. Curr Drug Discov Technol. 2010, 7: 170-187.",
      "volume": "7",
      "year": "2010"
    }
  ],
  "reference-count": 37,
  "references-count": 37,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/1479-7364-5-3-200"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "In silicotoxicology models and databases as FDA Critical Path Initiative toolkits"
  ],
  "type": "journal-article",
  "volume": "5"
}